Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

X4 Pharmaceuticals highlights 2024 as transformative with XOLREMDI's U.S. launch, international expansion, & Phase 3 trial progress.

U.S. enterprises are adopting GenAI-based services both to migrate mainframe workloads to the cloud and to keep their legacy systems productive, according to a new research report published today by ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent ...

SearchStax, the Search Experience company, has achieved a major milestone, surging into the Leaders quadrant of the G2 Grid® for Enterprise Search Software | Spring 2025 report, a 13-place leap from ...

Epigral Limited has successfully commissioned India's first Chlorotoluenes Value Chain Facility at its Dahej Complex in ...